Not exact matches
Unfortunately, the treatment had little effect
on the
survival of the terminally ill
lung cancer patients in the first trial.
Key findings in this study show that 5 - year
survival for older
lung cancer surgery patients is favorable; surgeons will be able to better individualize care for older
lung cancer patients based
on newly and uniquely linked data, and the prevalence of
lung cancer is expected to increase as the population continues to age.
Among patients with metastatic
lung cancer, comorbidity had less impact
on survival.
«We are planning to develop a
lung cancer - specific comorbidity index using prospective data for the best estimate of the impact of individual comorbid conditions
on survival.»
Injections of iPSC - EPCs did not however have significant effect
on tumor growth or
on overall
survival, but transducing cells with a baculovirus expressing CD40L, a member of the TNF gene family which can induce apoptosis [6, 7], and injection into the breast
cancer lung metastasis, increased levels of pro-apoptotic cytokines in
lung tissues, indicating the induction of apoptosis by CD40L carried by the EPCs (See figure).
The work that garnered the honor, «An analysis of the risk and benefit of neoadjuvant chemotherapy among patients undergoing surgery for non-small cell
lung cancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term sur
cancer,» examined data from more than 134,000 patients in the National
Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term sur
Cancer Database to assess the impact of neoadjuvant therapy
on perioperative outcomes, as well as long - term
survival.
Life table modelling
on the basis of these data estimated 33 % five year
survival in 65 year old patients with early stage non-small cell
lung cancer who continued to smoke compared with 70 % in those who quit smoking.
Studies
on the effects of GHRH antagonists
on prostate and
lung cancers demonstrated their ability to modulate signaling pathways involved in cellular proliferation,
survival, metastasis, and apoptosis.
The U.S. drug maker released a statement
on Monday saying that its Keynote - 010 study, a randomized Phase two - third trial, showed that patients who were taking two different doses of Keytruda (FDA - approved two mg / kg dose and treatment dose of 10 mg / kg given every three weeks) had longer
survival compared to those who took docetaxel, the drug widely used for non-small cell
lung cancer (NSCLC).
Survival times for dogs with
lung cancer usually varies from two months to two years depending
on the
cancer type and severity.
If the best oncologist in the world uses the world's best
cancer model to plot the probability distribution function of my
survival from the
lung cancer he has just diagnosed, and I get hit my a bus
on the way home from the appointment, is the model wrong?